The global OTC and DTC Infectious Disease Diagnostic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key OTC and DTC Infectious Disease Diagnostic players cover Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG and Hologic, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements
LPI (LP Information)' newest research report, the “OTC and DTC Infectious Disease Diagnostic Industry Forecast” looks at past sales and reviews total world OTC and DTC Infectious Disease Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected OTC and DTC Infectious Disease Diagnostic sales for 2023 through 2029. With OTC and DTC Infectious Disease Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC and DTC Infectious Disease Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global OTC and DTC Infectious Disease Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on OTC and DTC Infectious Disease Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OTC and DTC Infectious Disease Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC and DTC Infectious Disease Diagnostic and breaks down the forecast by technology, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC and DTC Infectious Disease Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC and DTC Infectious Disease Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by technology
PCR
Immunodiagnostics
Clinical Microbiology
INAAT
DNA Sequencing and NGS
DNA Microarrays
Others
Segmentation by application
Diagnostic Laboratories
Hospitals and Clinics
Academic Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Bio-Rad Laboratories Inc
BD
Bosch Healthcare Solutions GmbH
Danaher
ThermoFisher Scientific
Siemens AG
Roche Holding AG
Hologic, Inc.
Qiagen
Cardinal Health
Quest Diagnostics Incorporated
Ador Diagnostics
Akonni Biosystems, Inc.
Alveo Technologies
Binx Health Inc.
bioMérieux, Inc.
Curetis
Sysmex Europe GmbH
Diasorin S.p.A

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global OTC and DTC Infectious Disease Diagnostic Market Size 2018-2029 2.1.2 OTC and DTC Infectious Disease Diagnostic Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 OTC and DTC Infectious Disease Diagnostic Segment by Technology 2.2.1 PCR 2.2.2 Immunodiagnostics 2.2.3 Clinical Microbiology 2.2.4 INAAT 2.2.5 DNA Sequencing and NGS 2.2.6 DNA Microarrays 2.2.7 Others 2.3 OTC and DTC Infectious Disease Diagnostic Market Size by Technology 2.3.1 OTC and DTC Infectious Disease Diagnostic Market Size CAGR by Technology (2018 VS 2022 VS 2029) 2.3.2 Global OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Technology (2018-2023) 2.4 OTC and DTC Infectious Disease Diagnostic Segment by Application 2.4.1 Diagnostic Laboratories 2.4.2 Hospitals and Clinics 2.4.3 Academic Research Institutes 2.4.4 Others 2.5 OTC and DTC Infectious Disease Diagnostic Market Size by Application 2.5.1 OTC and DTC Infectious Disease Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Application (2018-2023) 3 OTC and DTC Infectious Disease Diagnostic Market Size by Player 3.1 OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Players 3.1.1 Global OTC and DTC Infectious Disease Diagnostic Revenue by Players (2018-2023) 3.1.2 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Players (2018-2023) 3.2 Global OTC and DTC Infectious Disease Diagnostic Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 OTC and DTC Infectious Disease Diagnostic by Regions 4.1 OTC and DTC Infectious Disease Diagnostic Market Size by Regions (2018-2023) 4.2 Americas OTC and DTC Infectious Disease Diagnostic Market Size Growth (2018-2023) 4.3 APAC OTC and DTC Infectious Disease Diagnostic Market Size Growth (2018-2023) 4.4 Europe OTC and DTC Infectious Disease Diagnostic Market Size Growth (2018-2023) 4.5 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size Growth (2018-2023) 5 Americas 5.1 Americas OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023) 5.2 Americas OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023) 5.3 Americas OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC OTC and DTC Infectious Disease Diagnostic Market Size by Region (2018-2023) 6.2 APAC OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023) 6.3 APAC OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe OTC and DTC Infectious Disease Diagnostic by Country (2018-2023) 7.2 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023) 7.3 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa OTC and DTC Infectious Disease Diagnostic by Region (2018-2023) 8.2 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023) 8.3 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global OTC and DTC Infectious Disease Diagnostic Market Forecast 10.1 Global OTC and DTC Infectious Disease Diagnostic Forecast by Regions (2024-2029) 10.1.1 Global OTC and DTC Infectious Disease Diagnostic Forecast by Regions (2024-2029) 10.1.2 Americas OTC and DTC Infectious Disease Diagnostic Forecast 10.1.3 APAC OTC and DTC Infectious Disease Diagnostic Forecast 10.1.4 Europe OTC and DTC Infectious Disease Diagnostic Forecast 10.1.5 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Forecast 10.2 Americas OTC and DTC Infectious Disease Diagnostic Forecast by Country (2024-2029) 10.2.1 United States OTC and DTC Infectious Disease Diagnostic Market Forecast 10.2.2 Canada OTC and DTC Infectious Disease Diagnostic Market Forecast 10.2.3 Mexico OTC and DTC Infectious Disease Diagnostic Market Forecast 10.2.4 Brazil OTC and DTC Infectious Disease Diagnostic Market Forecast 10.3 APAC OTC and DTC Infectious Disease Diagnostic Forecast by Region (2024-2029) 10.3.1 China OTC and DTC Infectious Disease Diagnostic Market Forecast 10.3.2 Japan OTC and DTC Infectious Disease Diagnostic Market Forecast 10.3.3 Korea OTC and DTC Infectious Disease Diagnostic Market Forecast 10.3.4 Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Forecast 10.3.5 India OTC and DTC Infectious Disease Diagnostic Market Forecast 10.3.6 Australia OTC and DTC Infectious Disease Diagnostic Market Forecast 10.4 Europe OTC and DTC Infectious Disease Diagnostic Forecast by Country (2024-2029) 10.4.1 Germany OTC and DTC Infectious Disease Diagnostic Market Forecast 10.4.2 France OTC and DTC Infectious Disease Diagnostic Market Forecast 10.4.3 UK OTC and DTC Infectious Disease Diagnostic Market Forecast 10.4.4 Italy OTC and DTC Infectious Disease Diagnostic Market Forecast 10.4.5 Russia OTC and DTC Infectious Disease Diagnostic Market Forecast 10.5 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Forecast by Region (2024-2029) 10.5.1 Egypt OTC and DTC Infectious Disease Diagnostic Market Forecast 10.5.2 South Africa OTC and DTC Infectious Disease Diagnostic Market Forecast 10.5.3 Israel OTC and DTC Infectious Disease Diagnostic Market Forecast 10.5.4 Turkey OTC and DTC Infectious Disease Diagnostic Market Forecast 10.5.5 GCC Countries OTC and DTC Infectious Disease Diagnostic Market Forecast 10.6 Global OTC and DTC Infectious Disease Diagnostic Forecast by Technology (2024-2029) 10.7 Global OTC and DTC Infectious Disease Diagnostic Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Abbott 11.1.1 Abbott Company Information 11.1.2 Abbott OTC and DTC Infectious Disease Diagnostic Product Offered 11.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Abbott Main Business Overview 11.1.5 Abbott Latest Developments 11.2 Bio-Rad Laboratories Inc 11.2.1 Bio-Rad Laboratories Inc Company Information 11.2.2 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Offered 11.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Bio-Rad Laboratories Inc Main Business Overview 11.2.5 Bio-Rad Laboratories Inc Latest Developments 11.3 BD 11.3.1 BD Company Information 11.3.2 BD OTC and DTC Infectious Disease Diagnostic Product Offered 11.3.3 BD OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 BD Main Business Overview 11.3.5 BD Latest Developments 11.4 Bosch Healthcare Solutions GmbH 11.4.1 Bosch Healthcare Solutions GmbH Company Information 11.4.2 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Offered 11.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Bosch Healthcare Solutions GmbH Main Business Overview 11.4.5 Bosch Healthcare Solutions GmbH Latest Developments 11.5 Danaher 11.5.1 Danaher Company Information 11.5.2 Danaher OTC and DTC Infectious Disease Diagnostic Product Offered 11.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Danaher Main Business Overview 11.5.5 Danaher Latest Developments 11.6 ThermoFisher Scientific 11.6.1 ThermoFisher Scientific Company Information 11.6.2 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Offered 11.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 ThermoFisher Scientific Main Business Overview 11.6.5 ThermoFisher Scientific Latest Developments 11.7 Siemens AG 11.7.1 Siemens AG Company Information 11.7.2 Siemens AG OTC and DTC Infectious Disease Diagnostic Product Offered 11.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Siemens AG Main Business Overview 11.7.5 Siemens AG Latest Developments 11.8 Roche Holding AG 11.8.1 Roche Holding AG Company Information 11.8.2 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Offered 11.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 Roche Holding AG Main Business Overview 11.8.5 Roche Holding AG Latest Developments 11.9 Hologic, Inc. 11.9.1 Hologic, Inc. Company Information 11.9.2 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product Offered 11.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Hologic, Inc. Main Business Overview 11.9.5 Hologic, Inc. Latest Developments 11.10 Qiagen 11.10.1 Qiagen Company Information 11.10.2 Qiagen OTC and DTC Infectious Disease Diagnostic Product Offered 11.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 Qiagen Main Business Overview 11.10.5 Qiagen Latest Developments 11.11 Cardinal Health 11.11.1 Cardinal Health Company Information 11.11.2 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Offered 11.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 Cardinal Health Main Business Overview 11.11.5 Cardinal Health Latest Developments 11.12 Quest Diagnostics Incorporated 11.12.1 Quest Diagnostics Incorporated Company Information 11.12.2 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Offered 11.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 Quest Diagnostics Incorporated Main Business Overview 11.12.5 Quest Diagnostics Incorporated Latest Developments 11.13 Ador Diagnostics 11.13.1 Ador Diagnostics Company Information 11.13.2 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Offered 11.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Ador Diagnostics Main Business Overview 11.13.5 Ador Diagnostics Latest Developments 11.14 Akonni Biosystems, Inc. 11.14.1 Akonni Biosystems, Inc. Company Information 11.14.2 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product Offered 11.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.14.4 Akonni Biosystems, Inc. Main Business Overview 11.14.5 Akonni Biosystems, Inc. Latest Developments 11.15 Alveo Technologies 11.15.1 Alveo Technologies Company Information 11.15.2 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Offered 11.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.15.4 Alveo Technologies Main Business Overview 11.15.5 Alveo Technologies Latest Developments 11.16 Binx Health Inc. 11.16.1 Binx Health Inc. Company Information 11.16.2 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Offered 11.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.16.4 Binx Health Inc. Main Business Overview 11.16.5 Binx Health Inc. Latest Developments 11.17 bioMérieux, Inc. 11.17.1 bioMérieux, Inc. Company Information 11.17.2 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Product Offered 11.17.3 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.17.4 bioMérieux, Inc. Main Business Overview 11.17.5 bioMérieux, Inc. Latest Developments 11.18 Curetis 11.18.1 Curetis Company Information 11.18.2 Curetis OTC and DTC Infectious Disease Diagnostic Product Offered 11.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.18.4 Curetis Main Business Overview 11.18.5 Curetis Latest Developments 11.19 Sysmex Europe GmbH 11.19.1 Sysmex Europe GmbH Company Information 11.19.2 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Offered 11.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.19.4 Sysmex Europe GmbH Main Business Overview 11.19.5 Sysmex Europe GmbH Latest Developments 11.20 Diasorin S.p.A 11.20.1 Diasorin S.p.A Company Information 11.20.2 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Offered 11.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) 11.20.4 Diasorin S.p.A Main Business Overview 11.20.5 Diasorin S.p.A Latest Developments 12 Research Findings and Conclusion